BMS-265246 | m-entrepreneurship.com

Product Name :
BMS-265246

Search keywords :
BMS-265246

drugId :
null

Target Vo:
Cyclin-dependent kinase 2

Target Vo Short Name :
CDK2

Moa_Name:
Cyclin-dependent kinase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bristol-Myers Squibb Company

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-eIF4G (Ser1108) Antibody
Hsp70 1B Antibody
S100A11 Antibody: S100A11 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 12 kDa, targeting to Protein S100-A11 (S100A11). It can be used for WB,IHC-P assays in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts